Evidence map›Paper›PMID 24269569›Full record

ArticleNeuroImage2014

Network dynamics predict improvement in working memory performance following donepezil administration in healthy young adults.

A Reches, I Laufer, K Ziv, G Cukierman, K McEvoy, M Ettinger, R T Knight, A Gazzaley, A B Geva

Registry-linked trialAbstract read
In one paragraph

Article in NeuroImage, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03269201 (Mapping Functional Networks of Brain Activity), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03269201 unknown statusnot on this mapstarted 2019, after this paper: background citation

Mapping Functional Networks of Brain Activity (Brain Network Activation, BNA) Based on Analysis of Evoked Response Potential (ERP) EEG Signals in Patients With Movement Disorders

TypeobservationalSponsorSheba Medical CenterRan2019 to 2022Enrolled300ConditionsParkinson Disease, Essential Tremor, Dystonia, Normal Pressure Hydrocephalus
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. A PAM of the αCurrent research in pharmacology and drug discovery · 2023
    Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

A RechesElMindA Ltd., Herzliya, Israel. Electronic address: amit@elminda.com.
I LauferElMindA Ltd., Herzliya, Israel.
K ZivElMindA Ltd., Herzliya, Israel.
G CukiermanElMindA Ltd., Herzliya, Israel.
K McEvoyUniversity of California, Los Angeles School of Medicine, Los Angeles, CA, USA.
M EttingerElMindA Ltd., Herzliya, Israel.
R T KnightHelen Wills Neuroscience Institute, University of California, Berkeley, CA, USA; Department of Psychology, University of California, Berkeley, CA, USA.
A GazzaleyDepartments of Neurology, Physiology and Psychiatry, University of California San Francisco, San Francisco, CA, USA.
A B GevaElMindA Ltd., Herzliya, Israel; Electrical and Computer Engineering, Ben Gurion University of the Negev, Beer Sheba, Israel.
Hewlett-Packard (Israel) · ILUniversity of California, Los Angeles · USUniversity of California, San Francisco · US

Funding

UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
ATTENTION, ORIENTATION, & THE HUMAN PREFRONTAL CORTEXR37NS021135 · NINDS · UNIVERSITY OF CALIFORNIA BERKELEY · PI KNIGHT, ROBERT THOMAS · 2013 to 2019
$3.6M
NIGMS NIH HHS T32 GM008042NINDS NIH HHS R37 NS021135
6 · The paper itself

Abstract

Attentional selection in the context of goal-directed behavior involves top-down modulation to enhance the contrast between relevant and irrelevant stimuli via enhancement and suppression of sensory cortical activity. Acetylcholine (ACh) is believed to be involved mechanistically in such attention processes. The objective of the current study was to examine the effects of donepezil, a cholinesterase inhibitor that increases synaptic levels of ACh, on the relationship between performance and network dynamics during a visual working memory (WM) task involving relevant and irrelevant stimuli. Electroencephalogram (EEG) activity was recorded in 14 healthy young adults while they performed a selective face/scene working memory task. Each participant received either placebo or donepezil (5mg, orally) on two different visits in a double-blinded study. To investigate the effects of donepezil on brain network dynamics we utilized a novel EEG-based Brain Network Activation (BNA) analysis method that isolates location-time-frequency interrelations among event-related potential (ERP) peaks and extracts condition-specific networks. The activation level of the network modulated by donepezil, reflected in terms of the degree of its dynamical organization, was positively correlated with WM performance. Further analyses revealed that the frontal-posterior theta-alpha sub-network comprised the critical regions whose activation level correlated with beneficial effects on cognitive performance. These results indicate that condition-specific EEG network analysis could potentially serve to predict beneficial effects of therapeutic treatment in working memory.

Indexed as

AdultBrain MappingBrain WavesCholinesterase InhibitorsDonepezilEvoked PotentialsFemaleHumansIndansMaleMemory, Short-TermMental RecallPattern Recognition, VisualPerformance-Enhancing SubstancesPiperidinesYoung AdultCholinesterase InhibitorsDonepezilIndansPerformance-Enhancing SubstancesPiperidinesBNACognitive enhancementDonepezilEEGWorking memory

Identifiers

PMID24269569
PMCPMC4096443
OpenAlexW2118155168

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.